[HTML][HTML] Multiple sclerosis: mechanisms and immunotherapy

C Baecher-Allan, BJ Kaskow, HL Weiner - Neuron, 2018 - cell.com
Multiple sclerosis (MS) is an autoimmune disease triggered by environmental factors that act
on a genetically susceptible host. It features three clinical stages: a pre-clinical stage …

[HTML][HTML] Multiple Sclerosis: Mechanisms and Immunotherapy

C Baecher-Allan, BJ Kaskow, HL Weiner - Neuron, 2018 - cell.com
Multiple sclerosis (MS) is an autoimmune disease triggered by environmental factors that act
on a genetically susceptible host. It features three clinical stages: a pre-clinical stage …

[引用][C] Multiple Sclerosis: Mechanisms and Immunotherapy

C Baecher-Allan, BJ Kaskow, HL Weiner - Neuron, 2018 - cir.nii.ac.jp
Multiple Sclerosis: Mechanisms and Immunotherapy | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

Multiple Sclerosis: Mechanisms and Immunotherapy.

C Baecher-Allan, BJ Kaskow, HL Weiner - Neuron, 2018 - europepmc.org
Multiple sclerosis (MS) is an autoimmune disease triggered by environmental factors that act
on a genetically susceptible host. It features three clinical stages: a pre-clinical stage …

Multiple Sclerosis: Mechanisms and Immunotherapy

C Baecher-Allan, BJ Kaskow, HL Weiner - Neuron, 2018 - pubmed.ncbi.nlm.nih.gov
Multiple sclerosis (MS) is an autoimmune disease triggered by environmental factors that act
on a genetically susceptible host. It features three clinical stages: a pre-clinical stage …

[HTML][HTML] Multiple Sclerosis: Mechanisms and Immunotherapy

C Baecher-Allan, BJ Kaskow, HL Weiner - Neuron, 2018 - Elsevier
Multiple sclerosis (MS) is an autoimmune disease triggered by environmental factors that act
on a genetically susceptible host. It features three clinical stages: a pre-clinical stage …

Multiple Sclerosis: Mechanisms and Immunotherapy

C Baecher-Allan, BJ Kaskow, HL Weiner - Neuron, 2018 - research-repository.uwa.edu.au
Multiple sclerosis (MS) is an autoimmune disease triggered by environmental factors that act
on a genetically susceptible host. It features three clinical stages: a pre-clinical stage …